COMMUNIQUÉS West-GlobeNewswire

OpGen Reports First Quarter 2018 Financial Results and Provides a Business Update
08/05/2018
Revenue increases 10% to $0.8 million, net loss decreases 39% to $3.0 million Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., May 08, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) today [...]
Dynavax Reports First Quarter 2018 Financial Results
08/05/2018
Update on Initial Progress of HEPLISAV-B ® Commercial Launch Conference Call to be Held at 4:30pm ET/1:30pm PT BERKELEY, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/05/2018
MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Xenon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
08/05/2018
Xenon’s novel clinical stage epilepsy candidates, XEN1101 and XEN901, to be presented at upcoming 14th Eilat Conference on New Antiepileptic Drugs and Devices on May 15, 2018 BURNABY, British Columbia, May 08, 2018 ( [...]
INSYS Therapeutics Announces Exclusive License Partnership with Lunatus to Commercialize SUBSYS® (fentanyl sublingual spray) in the Middle East
08/05/2018
PHOENIX, May 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today [...]
Bellicum Pharmaceuticals Reports First Quarter 2018 Financial Results
08/05/2018
HOUSTON, May 08, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Gemphire Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
08/05/2018
LIVONIA, Mich., May 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, [...]
MyoKardia Reports First Quarter 2018 Financial Results
08/05/2018
Company to Host Conference Call and Webcast Today at 4:30 p.m. ET (1:30 p.m. PT) SOUTH SAN FRANCISCO, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company [...]
Flexion Therapeutics Reports First-Quarter 2018 Financial Results and Recent Business Highlights
08/05/2018
Company booked net ZILRETTA ® sales of $2.2 million in Q1 Positive developments in Medicare reimbursement with CMS issuing Q code for ZILRETTA (effective 7/1/18) and recommending dedicated J code (effective 1/1/19) [...]
T2 Biosystems Reports First Quarter 2018 Financial Results and Provides Corporate Update
08/05/2018
Quarterly Product Revenue Up 66% Year-Over-Year On Track for Potential FDA Clearance of T2Bacteria Panel in the Second Quarter 2018 LEXINGTON, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ) [...]
Tempus Announces New Initiative to Support Physicians Efforts to Deliver Personalized Medicine
08/05/2018
CHICAGO, May 08, 2018 (GLOBE NEWSWIRE) -- Tempus today announced a new initiative that will allow physicians to sequence a second patient sample without additional charge, removing a barrier that oftentimes stands in [...]
GW Pharmaceuticals to Present at Bank of America Merrill Lynch 2018 Health Care Conference
08/05/2018
LONDON and CARLSBAD, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH ) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing [...]
Brain Tumor Advocates from Across the United States “Head to the Hill” to Meet with Members of Congress
08/05/2018
National Brain Tumor Society’s Annual Head to the Hill Advocacy Day puts brain tumor research funding, treatment development, and patient care on the legislative agenda in Washington, D.C. Washington, D.C., May 08, 2018 [...]
Emblem enters into Advisory Agreement with e.vestor Communications Inc.
08/05/2018
TORONTO, May 08, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSX-V: EMC ) (TSX-V:EMC.WT) (" Emblem " or the " Corporation ") is pleased to announce the appointment of e.vestor Communications Inc. (“ EVC ”) as the Corporation [...]
Altimmune to Announce First Quarter 2018 Financial Results on May 16
08/05/2018
GAITHERSBURG, Md., May 08, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the first quarter ended March [...]
CymaBay Therapeutics Announces the Initiation of a Phase 2b Study of Seladelpar in Patients with Non-Alcoholic Steatohepatitis
08/05/2018
NEWARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
CrownBio Demonstrates Advantages of Innovative Translational Oncology Platform in Scientific Posters at AACR 2018 Meeting
08/05/2018
SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing [...]
Teligent, Inc. Announces First Quarter 2018 Results
08/05/2018
BUENA, N.J., May 08, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter ended March 31, 2018 [...]
Editas Medicine to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
08/05/2018
CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced that it will participate in a fireside chat at the Bank of America Merrill [...]

Pages